glyoxal has been researched along with Atherosclerosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanssen, NM; Maessen, DE; Schalkwijk, CG; Scheijen, JL; Stehouwer, CD; van der Kallen, CJ; van Greevenbroek, MM | 1 |
| Abina, EA; Konovalova, GG; Kumskova, EM; Lankin, VZ; Tikhaze, AK; Viigimaa, M; Vlasik, TN; Yanushevskaya, EV; Zemtsovskaya, G | 1 |
| Shiriaeva, IuK; Titov, VN | 1 |
| Auge, N; Ayala, V; Cantero, AV; Elbaz, M; Nègre-Salvayre, A; Pamplona, R; Portero-Otín, M; Salvayre, R; Sanson, M; Thiers, JC | 1 |
4 other study(ies) available for glyoxal and Atherosclerosis
| Article | Year |
|---|---|
Post-Glucose Load Plasma α-Dicarbonyl Concentrations Are Increased in Individuals With Impaired Glucose Metabolism and Type 2 Diabetes: The CODAM Study.
Topics: Atherosclerosis; Blood Glucose; Chromatography, Liquid; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fasting; Female; Glucose Tolerance Test; Glycated Hemoglobin; Glyoxal; Humans; Hyperglycemia; Male; Mass Spectrometry; Middle Aged; Postprandial Period; Pyruvaldehyde | 2015 |
Interrelation between malonyl dialdehyde-dependent modification and cholesterol content in low-density lipoproteins.
Topics: Adult; Atherosclerosis; Biomarkers; Blood Glucose; Cholesterol; Cholesterol, LDL; Diabetes Mellitus; Estonia; Glyoxal; Humans; Immunochemistry; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Pyruvaldehyde; Spectrophotometry | 2010 |
[The glucose, glycotoxins and glycation products: the involvement into pathogenesis of microangiopathies, arteriolosclerosis and atherosclerosis].
Topics: Arteriolosclerosis; Atherosclerosis; Diabetes Mellitus; Diabetic Angiopathies; Glucose; Glutamic Acid; Glycation End Products, Advanced; Glycosylation; Glyoxal; Humans; Metabolic Networks and Pathways; Oxidation-Reduction; Proteolysis; Pyruvaldehyde; Vascular Diseases | 2011 |
Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis.
Topics: Animals; Aorta; Apolipoproteins E; Arginine; Atherosclerosis; Becaplermin; Cell Movement; Cell Proliferation; Cells, Cultured; Diabetes Complications; Diabetes Mellitus, Experimental; Glycation End Products, Advanced; Glyoxal; Guanidines; Humans; Mesoderm; Mice; Mice, Knockout; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-sis; Pyruvaldehyde; Rabbits; Receptor, Platelet-Derived Growth Factor beta | 2007 |